FrancophonIA/ELRC3.0 huggingface dataset:
English: current epidemiological studies (on about 100 children) do not suggest an increased risk of neurodevelopmental disorders or delays.
Slovenian: Vendar pa trenutne epidemiološke študije (pri približno 100 otrocih) ne kažejo na povečano tveganje za nevrološko razvojne motnje ali zaostalosti.
English: The film-coating contains:
Slovenian: Filmska obloga vsebuje:
English: He/she may decide if your dose should be adjusted.
Slovenian: Le ta se odloči, ali je vaš odmerek treba prilagoditi.
English: Dose and frequency(1) Infants 1 to less than 6 months
Slovenian: odmerjanje in pogostnost (1) Dojenčki od 1 do manj kot 6 mesecev
English: - Do not stop your treatment without your doctor's advice as this could increase your seizures.
Slovenian: • Ne prekinite zdravljenja brez nasveta svojega zdravnika, ker se lahko napadi še okrepijo.
English: You may take Levetiracetam Accord with or without food.
Slovenian: Jemljejo se lahko s hrano ali brez nje.
English: The patients had to present with unprovoked partial seizures or with generalized tonic-clonic seizures only.
Slovenian: Bolniki so morali imeti neizzvane parcialnih napade ali samo generalizirane tonično-klonične napade.
English: Epilepsy is a condition where the patients have repeated fits (seizures).
Slovenian: Epilepsija je stanje, kjer imajo bolniki ponavljajoče se krče (napade).
English: Prevalence is significantly higher in Japanese patients when compared to nonJapanese patients.
Slovenian: Pogostnost je bistveno višja pri japonskih bolnikih v primerjavi z ne-japonskimi bolniki.
English: • a more severe form of rash causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis)
Slovenian: • hujšo obliko, ki povzroči luščenje kože na več kot 30 % telesne površine (toksična epidermalna nekroliza)
English: ks= 0.45 in Term infants to 1 year old; ks= 0.55 in Children to less than 13 years and in adolescent female; ks= 0.7 in adolescent male
Slovenian: ks = 0,45 pri dojenčkih do 1 leta starosti; ks = 0,55 pri otrocih, mlajših od 13 let, in pri mladostnicah; ks = 0,7 pri mladostnikih moškega spola
English: Levetiracetam is used for the epilepsy form in which the fits initially affect only one side of the brain, but could thereafter extend to larger areas on both sides of the brain (partial onset seizure with or without secondary generalisation).
Slovenian: Levetiracetam se uporablja pri vrsti epilepsije, kjer krči na začetku prizadenejo eno stran možganov, kasneje pa se lahko razširijo na večje površine na obeh straneh možganov (parcialnih napadov s sekundarno generalizacijo ali brez nje).
English: Do not take macrogol (a drug used as laxative) for one hour before and one hour after taking levetiracetam as this may results in a loss of its effect.
Slovenian: Ne jemljite makrogola (učinkovina, ki se uporablja kot laksativ) eno uro pred in eno uro po jemanju levetiracetama, ker lahko zmanjša učinek levetiracetama.
English: Pharmacotherapeutic group: antiepileptics, other antiepileptics ATC code: N03AX14.
Slovenian: Farmakoterapevtska skupina: antiepileptiki, drugi antiepileptiki Oznaka ATC: N03AX14
English: Read all of this leaflet carefully before you or your child start taking this medicine because it contains important information for you.
Slovenian: Preden začnete vi ali vaš otrok uporabljati zdravilo, natančno preberite navodilo, ker vsebuje za vas pomembne podatke!
English: Accord Healthcare Limited Sage house, 319 Pinner road North Harrow HA1 4HF
Slovenian: Sage House, 319 Pinner Road North Harrow HA1 4HF
English: Example: if your daily dose is 1,000 mg, you might take 2 tablets of 250 mg in the morning and 2 tablets of 250 mg in the evening.
Slovenian: Na primer: če je vaš dnevni odmerek 1.000 mg, lahko vzamete 2 tableti po 250 mg zjutraj in 2 tableti po 250 mg zvečer.
English: There is no modification of the clearance after repeated administration.
Slovenian: Očistek se po ponavljajočem se dajanju ne spremeni.
English: Should your doctor decide to stop your Levetiracetam Accord treatment, he/she will instruct you about the gradual withdrawal of Levetiracetam Accord.
Slovenian: Če se bo vaš zdravnik odločil za prekinitev zdravljenja z zdravilom Levetiracetam Accord, vam bo dal napotke o postopni ukinitvi zdravila Levetiracetam Accord.
English: You should continue Levetiracetam Accord treatment for as long as your doctor has told you.
Slovenian: Levetiracetam Accord morate nadaljevati tako dolgo, kot vam je naročil zdravnik.
English: The other strengths of Levetiracetam tablets do not contain this ingredient.
Slovenian: Druge jakosti zdravila Levetiracetam Accord ne vsebujejo te sestavine.
English: For oral use
Slovenian: za peroralno uporabo
English: Adverse reactions are presented in the order of decreasing seriousness and their frequency is defined as follows: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) and very rare (<1/10,000).
Slovenian: Neželeni učinki so navedeni po padajoči resnosti in njihova pogostnost je opredeljena takole: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100),
English: Results related to behavioural and emotional functioning indicated a worsening in levetiracetam treated patients on aggressive behaviuor as measured in a standardised and systematic way using a validated instrument (CBCL - Achenbach Child Behavior Checklist).
Slovenian: Rezultati, povezani z vedenjskimi in emocionalnimi funkcijami, kažejo pri bolnikih, ki se zdravijo z levetiracetamom, poslabšanje agresivnega obnašanja, ki se izmeri na standardiziran in sistematičen način z uporabo validiranega merskega instrumenta (CBCL - Achenbach Child Behavior Checklist).
English: Furthermore, levetiracetam has been shown in in vitro studies to bind to a specific site in rodent brain tissue.
Slovenian: Nadalje se je za levetiracetam v in vitro študijah pokazalo, da se veže na specifično mesto v možganskem tkivu glodavcev.
English: Adverse reactions reported in clinical studies (adults, adolescents, children and infants> 1 month) and from post-marketing experience are listed in the following table per System Organ Class and per frequency.
Slovenian: Neželeni učinki, o katerih so poročali v kliničnih študijah (odrasli, mladostniki, otroci in dojenčki, starejši od 1 meseca) in v postmarketinškem obdobju, so navedeni v spodnji tabeli po organskih sistemih in pogostnosti.
English: Due to possible different individual sensitivity, some patients might experience somnolence or other central nervous system related symptoms, especially at the beginning of treatment or following a dose increase.
Slovenian: Pri nekaterih bolnikih se lahko zaradi različne individualne občutljivosti predvsem na začetku zdravljenja ali po povečanju odmerka pojavijo somnolenca ali drugi simptomi, povezani s centralnim živčnim sistemom.
English: Hypersensitivity to the active substance or other pyrrolidone derivatives or to any of the excipients listed in section 6.1.
Slovenian: Preobčutljivost na zdravilno učinkovino ali druge pirolidonske derivate ali katerokoli pomožno snov je navedena v poglavju 6.1.
English: When you will first start taking Levetiracetam Accord, your doctor will prescribe you a lower dose (500 mg each day) during 2 weeks before giving you the lowest general dose of 1000 mg.
Slovenian: Na začetku jemanja zdravila Levetiracetam Accord vam bo zdravnik, preden vam bo predpisal najmanjši običajni odmerek 1.000 mg, za dva tedna predpisal manjši odmerek (500 mg na dan).
English: • on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy, to treat a certain form of epilepsy.
Slovenian: • za samostojno zdravljenje pri odraslih in mladostnikih od 16. leta starosti, z na novo diagnosticirano epilepsijo, za zdravljenje določene oblike epilepsije.
English: Pre-marketing data from clinical studies conducted in adults indicate that levetiracetam did not influence the serum concentrations of existing antiepileptic medicinal products (phenytoin, carbamazepine, valproic acid, phenobarbital, lamotrigine, gabapentin and primidone) and that these antiepileptic medicinal products did not influence the pharmacokinetics of levetiracetam.
Slovenian: Predmarketinški podatki iz kliničnih študij, izvedenih pri odraslih, kažejo, da levetiracetam ne vpliva na serumsko koncentracijo drugih protiepileptičnih zdravil (fenitoina, karbamazepina, valprojske kisline, fenobarbitala, lamotrigina, gabapentina in primidona), in da ta protiepileptična zdravila ne vplivajo na farmakokinetiko levetiracetama.
English: Due to its complete and linear absorption, plasma levels can be predicted from the oral dose of levetiracetam expressed as mg /kg bodyweight.
Slovenian: Zaradi popolne in linearne absorpcije je koncentracijo levetiracetama v plazmi mogoče predvideti na podlagi peroralnega odmerka, izraženega v mg/kg telesne mase.
English: The tablet formulation is not adapted for use in infants and children under the age of 6 years.
Slovenian: Farmacevtska oblika tablet ni prilagojena za uporabo pri dojenčkih in otrocih, mlajših od 6 let.
English: If levetiracetam has to be discontinued it is recommended to withdraw it gradually (e.g. in adults and adolescents weighing more than 50 kg: 500 mg decreases twice daily every two to four weeks; in infants older than 6 months, children and adolescents weighting less than 50 kg: dose decrease should not exceed 10 mg/kg twice daily every two weeks; in infants (less than 6 months): dose decrease should not exceed 7 mg/kg twice daily every two weeks).
Slovenian: Če je treba zdravljenje z levetiracetamom prekiniti, je priporočljivo zdravljenje opustiti postopno (npr. pri odraslih in mladostnikih, težkih več kot 50 kg: zmanjševanje odmerka za 500 mg dvakrat na dan na vsaka dva tedna do štiri tedne; pri dojenčkih, starejših od 6 mesecev, otrocih in mladostnikih s telesno maso manj kot 50 kg: zmanjšanje odmerka ne sme preseči 10 mg/kg dvakrat na dan vsaka dva tedna; pri dojenčkih (mlajših od 6 mesecev): zmanjšanje odmerka ne sme preseči 7 mg/kg dvakrat na dan vsaka dva tedna).
English: At 3600 mg /kg/day, in only one of the 2 EFD studies, there was a slight decrease in foetal weight associated with a marginal increase in skeletal variations/minor anomalies.
Slovenian: Pri 3.600 mg/kg/dan se je samo v eni od dveh študij embriofetalnega razvoja telesna masa plodu rahlo zmanjšala v povezavi z marginalnim povečanjem skeletnih sprememb/manjših anomalij.
English: What Levetiracetam Accord is and what it is used for What you need to know before you take Levetiracetam Accord How to take Levetiracetam Accord Possible side effects
Slovenian: Kaj je zdravilo Levetiracetam Accord in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Levetiracetam Accord Kako jemati zdravilo Levetiracetam Accord Možni neželeni učinki
English: 10 film-coated tablets 20 film-coated tablets 30 film-coated tablets 50 film-coated tablets 60 film-coated tablets 100 film-coated tablets 200 film-coated tablets 30 X 1 film-coated tablet 60 X 1 film-coated tablet 100 X 1 film-coated tablet
Slovenian: 10 filmsko obloženih tablet 20 filmsko obloženih tablet 30 filmsko obloženih tablet 50 filmsko obloženih tablet 60 filmsko obloženih tablet 100 filmsko obloženih tablet 200 filmsko obloženih tablet 30 X 1 filmsko obloženih tablet 60 X 1 filmsko obloženih tablet 100 X 1 filmsko obloženih tablet
English: If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Slovenian: Če imate dodatna vprašanja o uporabi tega zdravila, se posvetujte s svojim zdravnikom ali s farmacevtom.
English: How to store Levetiracetam Accord Contents of the pack and other information
Slovenian: Shranjevanje zdravila Levetiracetam Accord Vsebina pakiranja in dodatne informacije
English: See leaflet for further information.
Slovenian: Za več informacij si preberite priloženo navodilo.
English: Levetiracetam Accord may impair your ability to drive or operate any tools or machinery, as it may make you feel sleepy.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Zdravilo Levetiracetam Accord lahko oslabi vašo sposobnost vožnje ali upravljanja z orodjem ali stroji, saj lahko povzroči zaspanost.
English: Marketing authorization holder and manufacturer Marketing authorization holder Accord Healthcare S.L.U.
Slovenian: Imetnik dovoljenja za promet z zdravilom in izdelovalec Imetnik dovoljenja za promet z zdravilom Accord Healthcare S.L.U.
English: Creatinine clearance (ml/min/1.73m2)
Slovenian: skupina očistek kreatinina (ml/min/1,73m2)
English: 43.6% of the levetiracetam treated patients and 19.6% of the patients on placebo were considered as responders.
Slovenian: 43,6 % bolnikov, ki so se zdravili z levetiracetamom in 19,6 % bolnikov, ki so prejemali placebo, se je na zdravljenje odzvalo.
English: In addition it partially reverses the reductions in GABA- and glycine-gated currents induced by zinc and β-carbolines.
Slovenian: Poleg tega delno preprečuje inhibicijo GABA in glicinskih kanalčkov povzročeno z Zn2+ in β- karbolini.
English: If you forget to take Levetiracetam Accord Contact your doctor if you have missed one or more doses.
Slovenian: Če ste pozabili vzeti zdravilo Levetiracetam Accord Če ste pozabili vzeti enega ali več odmerkov, se posvetujte s svojim zdravnikom.
English: It is therefore recommended to adjust the maintenance daily dose of levetiracetam, based on creatinine clearance in patients with moderate and severe renal impairment (see section 4.2).
Slovenian: Zato je priporočljivo dnevni vzdrževalni odmerek zdravila Levetiracetam pri bolnikih z zmerno in hudo ledvično okvaro prilagoditi očistku kreatinina (glejte poglavje 4.2).
English: • skin rash, which may form blisters and looks like small targets (central dark spots surrounded by a paler area, with a dark ring around the edge) (erythema multiforme), a widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (StevensJohnson syndrome), and a more severe form causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis).
Slovenian: • kožni izpuščaj, ki lahko tvori mehurčke in izgleda kot majhne tarče (na sredini temne pike obkrožene s svetlejšim delom in s temnim krogom na robu) (multiformni eritem), široko razširjen izpuščaj z mehurčki in luščenjem kože, še posebej okoli ust, nosu, oči in v predelu spolovil (Stevens-Johnsonov sindrom) in bolj huda oblika, ki povzroči luščenje kože na več kot 30 % telesne površine (toksična epidermalna nekroliza).
English: In a pooled analysis, the percentage of patients who achieved 50% or greater reduction from baseline in the partial onset seizure frequency per week at stable dose (12/14 weeks) was of 27.7%, 31.6% and 41.3% for patients on 1000, 2000 or 3000 mg levetiracetam respectively and of 12.6% for patients on placebo.
Slovenian: Delež bolnikov iz zbranih analiz, pri katerih je bilo doseženo 50- ali več odstotno zmanjšanje pogostnosti parcialnih napadov na teden pri stalnem odmerku (12/14 tednov), je bil 27,7 % pri bolnikih, ki so prejemali 1.000 mg, 31,6 % pri bolnikih, ki so prejemali 2.000 mg in 41,3 % pri bolnikih, ki so prejemali 3.000 mg levetiracetama, ter 12,6 % pri bolnikih, ki so prejemali placebo.
English: The dose level of 1800 mg/kg/day induced a marked maternal toxicity and a decrease in foetal weight associated with increased incidence of foetuses with cardiovascular/skeletal anomalies.
Slovenian: Odmerki 1.800 mg/kg/dan so sprožili izrazito toksičnost pri samicah in zmanjšanje telesne mase plodov, povezano s povečanjem pogostnosti zarodkov s kardiovaskularnimi/skeletnimi anomalijami.
English: Dose in adults and adolescents (from 16 years of age) General dose: between 1000 mg and 3,000 mg each day.
Slovenian: Odmerjanje pri odraslih in mladostnikih (od 16. leta starosti) Običajni odmerek: med 1.000 mg in 3.000 mg na dan.
English: • decreased blood sodium concentrations
Slovenian: • znižana koncentracija natrija v krvi
English: In adults, levetiracetam efficacy has been demonstrated in 3 double-blind, placebo-controlled studies at 1000 mg, 2000 mg, or 3000 mg /day, given in 2 divided doses, with a treatment duration of up to 18 weeks.
Slovenian: Pri odraslih je bila učinkovitost levetiracetama dokazana v 3 dvojno slepih, s placebom nadzorovanih študijah s 1.000 mg, 2.000 mg ali 3.000 mg/dan, razdeljenih na dva odmerka, ter s trajanjem zdravljenja do 18 tednov.
English: Other medicines and Levetiracetam Accord Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Slovenian: Obvestite svojega zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katerokoli drugo zdravilo.
English: Acute Kidney injury
Slovenian: Akutna poškodba ledvic
English: In both population pharmacokinetic analyses, there was about a 20% increase of apparent clearance of levetiracetam when it was co-administered with an enzyme-inducing antiepileptic medicinal product.
Slovenian: V obeh farmakokinetičnih analizah populacije se je navidezni očistek levetiracetama pri sočasni uporabi protiepileptičnega zdravila, ki inducira encime, povečal za približno 20 %.
English: 500 to 1, 500 mg twice daily 500 to 1,000 mg twice daily 250 to 750 mg twice daily 250 to 500 mg twice daily 500 to 1,000 mg once daily (2)
Slovenian: 250 do 750 mg dvakrat na dan 250 do 500 mg dvakrat na dan 500 do 1.000 mg enkrat na dan(2)
English: This includes, any possible side effects not listed in this leaflet.
Slovenian: Posvetujte se tudi, če opazite katere koli neželene učinke, ki niso navedeni v tem navodilu.
English: In all of the above cases levetiracetam oral solution should be used.
Slovenian: V vseh teh primerih se mora uporabiti peroralna raztopina levetiracetam.
English: Only limited evidence is available on the neurodevelopment of children exposed to levetiracetam monotherapy in utero.
Slovenian: O nevrološkem razvoju otrok, ki so bili in utero izpostavljeni zdravilu levetiracetama, uporabljenim samostojno, so na voljo samo omejeni dokazi.
English: A significant correlation between saliva and plasma concentrations has been shown in adults and children (ratio of saliva/plasma concentrations ranged from 1 to 1.7 for oral tablet formulation and after 4 hours post-dose for oral solution formulation).
Slovenian: Pri odraslih in otrocih so ugotovili pomembno povezavo med koncentracijo v plazmi in slini (razmerje koncentracij v slini/plazmi se giblje med 1 in 1,7 za tableto in za peroralno uporabo in za peroralno raztopino 4 ure po odmerku).
English: If you have any further questions, ask your doctor or pharmacist.
Slovenian: − Če imate dodatna vprašanja, se posvetujte s svojim zdravnikom ali s farmacevtom.
English: Do not use this medicine after the expiry date which is stated on carton box and blister after EXP.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka uporabnosti, ki je naveden na škatli in pretisnem omotu poleg oznake EXP. Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca.
English: The primary measure of effectiveness was the responder rate (percent of patients with ≥ 50% reduction from baseline in average daily partial onset seizure frequency) assessed by a blinded central reader using a 48-hour video EEG.
Slovenian: Osnovno merilo učinkovitosti je bila stopnja odziva (odstotek bolnikov z znižanjem ≥ 50 % povprečnih pogostosti parcialnih napadov na dan glede na začetne vrednosti), ki jo je na 48-urnem EEG posnetku določil ocenjevalec, ki ni vedel, kdo je prejemal placebo in kdo zdravilo.
English: The patients were randomized to carbamazepine CR 400 - 1200 mg /day or levetiracetam 1000 - 3000 mg /day, the duration of the treatment was up to 121 weeks depending on the response.
Slovenian: Bolniki so randomizirano prejemali 400-1.200 mg karbamazepina z nadzorovanim sproščanjem (CR) na dan ali 1.000-3.000 mg levetiracetama na dan, trajanje zdravljenja pa je bilo do 121 tednov, odvisno od odziva.
English: The CLcr in ml/min/1.73 m2 may be estimated from serum creatinine (mg/dl) determination, for young adolescents,children and infants, using the following formula (Schwartz formula):
Slovenian: CLcr v ml/min/1,73 m2 je pri mlajših mladostnikih, otrocih in dojenčkih, mogoče oceniti iz koncentracije kreatinina v serumu (mg/dl) z uporabo naslednje formule (po Schwartz-evi formuli):
English: A peri- and post-natal development study was performed in rats with levetiracetam doses of 70, 350 and 1800 mg/kg/day.
Slovenian: Peri- in postnatalno študijo razvoja so izvedli pri podganah z odmerki levetiracetama po 70, 350 in 1.800 mg/kg/dan.
English: In this study, the patients received levetiracetam as a fixed dose of 60 mg /kg/day (with twice a day dosing).
Slovenian: V tej študiji so bolniki prejemali stalen odmerek 60 mg/kg/dan (odmerjanje dvakrat na dan).
English: Two embryo-foetal development (EFD) studies were performed in rats at 400, 1200 and 3600 mg /kg/day.
Slovenian: Dve študiji embriofetalnega razvoja pri podganah so izvedli z odmerki 400, 1.200 in 3.600 mg/kg/dan.
English: In this study, levetiracetam dose was 3000 mg /day for adults and adolescents or 60 mg /kg/day for children, given in 2 divided doses.
Slovenian: V tej študiji je bil odmerek levetiracetama za odrasle in mladostnike 3.000 mg na dan, za otroke pa 60 mg/kg/dan, razdeljen na dva odmerka.
English: Dose in adults and adolescents (12 to 17 years) weighing 50 kg or more General dose: between 1,000 mg and 3,000 mg each day.
Slovenian: Odmerjanje pri odraslih in mladostnikih (od 12 do 17 let), težkih 50 kg ali več Običajni odmerek med 1.000 mg in 3.000 mg na dan.
English: No new safety concerns for levetiracetam were identified for infants less than 12 months of age with epilepsy.
Slovenian: Pri dojenčkih z epilepsijo, mlajših od 12 let, niso ugotovili nobenih novih pomislekov glede varnosti za levetiracetam.
English: Following repeated oral dose administration (20 to 60 mg /kg/day) to epileptic children (4 to 12 years), levetiracetam was rapidly absorbed.
Slovenian: Po uporabi večkratnih peroralnih odmerkov (od 20 do 60 mg/kg/dan) pri otrocih z epilepsijo (od 4 do 12 let) se je levetiracetam hitro absorbiral.
English: Therefore there is no need for plasma level monitoring of levetiracetam.
Slovenian: Koncentracije levetiracetama v plazmi zato ni treba kontrolirati.
English: Swallow Levetiracetam Accord with a sufficient quantity of liquid (e.g. a glass of water).
Slovenian: Tablete Levetiracetam Accord zaužijte z dovolj tekočine (npr. s kozarcem vode).
English: In paediatric patients (1 month to less than 4 years of age), levetiracetam efficacy was established in a double-blind, placebo-controlled study, which included 116 patients and had a treatment duration of 5days.
Slovenian: Pri pediatričnih bolnikih (od 1 meseca do manj kot 4. leta starosti) je bila učinkovitost levetiracetama dokazana v dvojno slepi, s placebom nadzorovani študiji, ki je vključevala 116 bolnikov in je trajala 5 dni.
English: Adjustment of the dose is recommended in elderly patients with compromised renal function (see “Renal impairment” below).
Slovenian: Pri starejših bolnikih z okvarjenim delovanjem ledvic je priporočljiva prilagoditev odmerka (glejte spodaj »Bolniki z ledvično okvaro«).
English: Levetiracetam 1,000 mg daily did not influence the pharmacokinetics of oral contraceptives (ethinyl-estradiol and levonorgestrel); endocrine parameters (luteinizing hormone and progesterone) were not modified.
Slovenian: Peroralni kontraceptivi in druge farmakokinetične interakcije Levetiracetam v odmerku 1.000 mg na dan ni vplival na farmakokinetiko peroralnih kontraceptivov (etinilestradiola in levonorgestrela); endokrini parametri (luteinizirajoči hormon in progesteron) se niso spremenili.
English: If you take more Levetiracetam Accord than you should The possible side effects of an overdose of Levetiracetam are sleepiness, agitation, aggression, decrease of alertness, inhibition of breathing and coma.
Slovenian: Če ste vzeli večji odmerek zdravila Levetiracetam Accord, kot bi smeli Možni neželeni učinki pri prevelikem odmerjanju zdravila Levetiracetam Accord so zaspanost, agitacija (motorični nemir), agresivnost, zmanjšana budnost, upočasnitev dihanja in koma.